This study aims to evaluate the effect of hydroxyapatite-containing toothpaste and mouthwash in preventing white spot lesions in patients undergoing orthodontic treatment. Participants: 75 patients will be divided into three groups: * Group A: Participants will brush their teeth three times a day using hydroxyapatite toothpaste and rinse twice a day with a placebo mouthwash. * Group B: Participants will brush their teeth three times a day using fluoride toothpaste and rinse twice a day with hydroxyapatite mouthwash. * Group C (Control Group): Participants will brush their teeth three times a day using fluoride toothpaste and rinse twice a day with a placebo mouthwash. Patients will be followed during their orthodontic treatment to assess the development of white spot lesions. The study is safe and involves no surgical procedures or risky medications, and will be conducted under the supervision of Principal Investigator Heba Masri after obtaining ethical approval.
This randomized, three-group study aims to evaluate the effectiveness of hydroxyapatite in preventing white spot lesions during orthodontic treatment in patients who initially do not have these lesions. Study Design: * Total Participants: 75 patients (25 per group) * Duration: Throughout orthodontic treatment * Groups: * Group A: Brush teeth three times daily with hydroxyapatite toothpaste and rinse twice daily with placebo mouthwash. * Group B: Brush teeth three times daily with fluoride toothpaste and rinse twice daily with hydroxyapatite mouthwash. * Group C (Control): Brush teeth three times daily with fluoride toothpaste and rinse twice daily with placebo mouthwash. Outcome Assessments: All assessments of white-spot lesions will be performed using Diagnodent Pen, Gorlick index (GI), digital photographs, Gingival Bleeding Index (GBI), Plaque Index (PI), and salivary pH measurements. Ethical Considerations: * All participants will sign informed consent prior to joining the study. * The study was approved by the Ethics Committee, College of Dentistry, University of Baghdad. * This study involves low-risk interventions (toothpaste and mouthwash) and does not use U.S. FDA-regulated drugs or devices. Study Objective: * To determine whether hydroxyapatite-containing toothpaste and/or mouthwash is more effective than conventional products in preventing white spot lesions during orthodontic treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Enrollment
75
Participants will brush their teeth three times daily with hydroxyapatite-containing toothpaste to evaluate its effect on preventing white spot lesions during orthodontic treatment.
Participants will rinse their mouth twice daily with hydroxyapatite-containing mouthwash to assess its preventive effect on white spot lesions in orthodontic patients.
Participants will brush their teeth three times daily with fluoride toothpaste and rinse twice daily with placebo mouthwash, serving as the control group for comparison with hydroxyapatite interventions.
University of Baghdad - College of Dentistry / Orthodontic Clinic
Baghdad, Iraq
RECRUITINGSeverity of White Spot Lesions assessed by Gorelick Index
Severity of white spot lesions on labial tooth surfaces assessed using the Gorelick index during orthodontic treatment. Time Frame: Baseline to 6 months Unit of Measure: Score
Time frame: Baseline, 1,3 months, and 6 months
Enamel Demineralization assessed by DIAGNOdent
Enamel demineralization level measured using DIAGNOdent laser fluorescence device during orthodontic treatment. Unit of Measure: DIAGNOdent score (laser fluorescence units)
Time frame: Baseline, 1,3 months, and 6 months
Plaque Index
Plaque accumulation assessed using a standardized plaque index during orthodontic treatment.
Time frame: Baseline, 1, 3 months, 6 months
Gingival Bleeding Index
Gingival bleeding assessed using a standardized bleeding index during orthodontic treatment.
Time frame: Baseline, 1,3to and 6 months
Salivary pH
Salivary pH measured using pH indicator strips during orthodontic treatment. pH value
Time frame: Baseline, 1,3 and 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.